SAR260301
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SAR260301, covering 2015-04-10 to 2015-04-10. Get the full timeline:
Most recent: Clinical Trial Update: A Phase I/Ib Trial for the Evaluation of SAR260301 in Monotherapy or in Combination With Vemurafenib in Patients With Various Advanced Cancer [Phase 1]